What are the types of diabetes mellitus and what are their causes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Types of Diabetes and Their Causes

Diabetes mellitus is classified into four main categories: Type 1 diabetes (autoimmune β-cell destruction leading to absolute insulin deficiency), Type 2 diabetes (progressive loss of β-cell insulin secretion on a background of insulin resistance), specific types due to other causes (monogenic, drug-induced, pancreatogenic, endocrine disorders), and gestational diabetes mellitus. 1

Type 1 Diabetes

Cause: Autoimmune destruction of pancreatic β-cells, ultimately leading to absolute insulin deficiency 1, 2. This includes latent autoimmune diabetes in adults (LADA), which presents more variably in adults and may progress to insulin dependence more slowly than in children.

Key Features:

  • Can occur at any age, not just in children (the traditional paradigm is outdated) 1
  • Children typically present with classic polyuria/polydipsia, with approximately 50% presenting in diabetic ketoacidosis (DKA)
  • Adults may not present with classic symptoms and have slower progression
  • Characterized by presence of islet autoantibodies 1
  • Three distinct stages have been defined based on autoantibody presence and glucose progression 2

Type 2 Diabetes

Cause: Non-autoimmune progressive loss of adequate β-cell insulin secretion, typically occurring on a background of insulin resistance 1, 2.

Key Features:

  • Can occur at any age, not exclusively in adults 1
  • Frequently associated with metabolic syndrome 2
  • No islet autoantibodies present
  • Progressive β-cell dysfunction over time

Specific Types of Diabetes Due to Other Causes (Type 3)

This heterogeneous category encompasses multiple distinct causes 3, 4:

Monogenic Diabetes:

  • Maturity-onset diabetes of the young (MODY)
  • Neonatal diabetes
  • Genetic syndromes: Down syndrome, Klinefelter syndrome, Turner syndrome 3, 4

Endocrine Disorders:

  • Acromegaly
  • Cushing's disease/hypercortisolism
  • Glucagonoma 3, 4

Drug-Induced Diabetes:

  • Glucocorticoids
  • Immune checkpoint inhibitors
  • Calcineurin inhibitors
  • Phosphatidylinositol 3 kinase inhibitors
  • Highly active antiretroviral therapy (HAART)
  • Antipsychotic medications 3, 4

Pancreatogenic Diabetes:

  • Post-pancreatic surgery
  • Chronic or acute pancreatitis
  • Pancreatic tumors
  • Hemochromatosis
  • Cystic fibrosis 3, 4

Rare Forms:

  • Infection-triggered (congenital rubella syndrome)
  • Autoimmune forms other than type 1 (Stiff-person syndrome, anti-insulin receptor antibodies, insulin autoimmune syndrome) 3

Gestational Diabetes Mellitus (GDM)

Cause: Diabetes diagnosed in the second or third trimester of pregnancy that was not clearly overt diabetes prior to gestation 1, 2. This category also includes other types of diabetes (such as type 1) occurring throughout pregnancy.

Critical Clinical Considerations

Common Diagnostic Pitfall: Misdiagnosis occurs in up to 40% of adults with new-onset type 1 diabetes, who are frequently misclassified as having type 2 diabetes 2. Adults with type 1 diabetes may not present with classic symptoms and can be mistakenly treated with oral agents when insulin is required.

Classification Challenges:

  • Some individuals cannot be clearly classified at diagnosis 1
  • Both type 1 and type 2 diabetes are heterogeneous with variable clinical presentation and progression 1, 5
  • The diagnosis becomes clearer over time as the degree of β-cell deficiency manifests 2

Why Accurate Classification Matters: Precise diagnosis is critical for optimal treatment selection 3, 4. For example, identifying monogenic diabetes may completely change management from insulin to oral sulfonylureas in certain MODY subtypes, while recognizing drug-induced diabetes may allow for medication adjustment rather than lifelong diabetes therapy.

Related Questions

What are the current diagnostic criteria for diabetes mellitus according to guidelines?
In a 30-year-old patient with a 15-year history of diabetes mellitus, should I perform a workup to differentiate type 1 diabetes from type 2 diabetes?
What preconception management should I, as a diabetologist, provide for a 30-year-old woman with type 2 diabetes mellitus for 3 years, hemoglobin A1c 6.4%, currently taking sitagliptin, metformin, and glimepiride, with a body mass index of 24, who wishes to become pregnant in the next 3–4 months?
In a 64-year-old diabetic male with severe right hip pain radiating to the mid-thigh and concurrent right hand joint pain, what imaging studies are recommended, including plain‑film radiographs, MRI, and DEXA scan?
In a 70‑year‑old female nursing home resident with finger‑stick blood glucose ranging from 70 to 500 mg/dL who is currently on a sliding‑scale regimen of insulin glargine (Lantus) 12 units when glucose >200 mg/dL and insulin lispro (Humalog) 6 units twice daily when glucose >200 mg/dL, what is the recommended treatment approach?
What is the recommended management for a patient diagnosed with Swyer syndrome?
Why do individuals with Hyper‑IgE (Job) syndrome develop cold abscesses?
What are the key considerations for initiating non‑invasive ventilation in a patient with acute hypercapnic respiratory failure due to chronic obstructive pulmonary disease, and what is the recommended diagnostic approach for a young adult with unexplained chronic cough and dyspnea when interstitial lung disease is suspected?
Do paclitaxel and carboplatin increase monocyte and eosinophil counts?
Is there any rationale or indication for using a glucagon‑like peptide‑1 receptor agonist together with a dipeptidyl peptidase‑4 inhibitor in a patient with type 2 diabetes?
What medications are appropriate for an adult with COVID‑19 who has post‑tussive emesis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.